Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.47 |
| ▸ | ABCC1 | P33527 | 11/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 11/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 10/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25500829 | 0.91 | DRD2 (0.49) | DRD2HRH4HRH3 | |
| SCHEMBL25494745 | 0.90 | DRD2 (0.42) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL25494740 | 0.90 | DRD2 (0.42) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL25494738 | 0.90 | DRD2 (0.42) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL25974512 | 0.89 | DRD2 (0.44) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL26850302 | 0.89 | DRD2 (0.44) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL25494737 | 0.89 | DRD2 (0.41) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL25978158 | 0.88 | DRD2 (0.42) | DRD2ABCC1ABCG2ABCB1HRH3 | |
| SCHEMBL24334739 | 0.85 | DRD2 (0.40) | DRD2ABCC1ABCG2ABCB1DRD4 | |
| SCHEMBL27410882 | 0.85 | DRD2 (0.40) | DRD2ABCC1ABCG2ABCB1DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230366885-A1 | DNA CONSTRUCTS, RECOMBINANT CELLS COMPRISING THEREOF, BACTERIAL PROBES, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| US-20230366885-A1 | DNA CONSTRUCTS, RECOMBINANT CELLS COMPRISING THEREOF, BACTERIAL PROBES, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| US-11639929-B2 | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-05-02 | — | — | US | disclosed |
| US-11639929-B2 | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-05-02 | — | — | US | disclosed |
| US-20200256857-A1 | UNIVERSAL HISTIDINE-TAG BINDING COMPOUNDS AND METHODS OF USE THEREOF AS FLUORESCENT PROBES AND SENSORS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639929-B2 | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors | HCLS1, PHF6, PHPT1 | DRD2 4567/4885ABCC1 3028/4885ABCG2 458/4885 |
| US-20200256857-A1 | UNIVERSAL HISTIDINE-TAG BINDING COMPOUNDS AND METHODS OF USE THEREOF AS FLUORESCENT PROBES AND SENSORS | HCLS1, PHF6, PHPT1 | DRD2 4567/4885ABCC1 3028/4885ABCG2 458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.